GSD NovaType -Detect + Select K417N SARS-CoV-2 Assay
The GSD NovaType Detect + Select K417N SARS-CoV-2 is a research use only (RUO) real-time reverse transcription PCR (RT-PCR) assay designed for the simultaneous qualitative detection of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) genomic RNA and identification of the spike (S) gene mutation K417N. It is intended to aid in the identification of SARS-CoV-2 variant of concern (VOC) Omicron.
- Identification of SARS-CoV-2 N gene ( N1/N2) and mutation K417N in one reaction
- Specimen types: nasal wash/swab, nasopharyngeal swab, oropharyngeal swab
- Validated PCR platforms: AriaMxTM, AriaDxTM (Agilent Technologies)
- RUO
- GSD NovaType Detect + Select K417N SARS-CoV-2 - Prod. No.: PCOV6181 - 1 x 96 reactions
- GSD NovaType Detect + Select K417N SARS-CoV-2 - Prod. No.: PCOV6184 - 4 x 96 reactions
Disease
COVID-19 is the official name for the new infectious disease declared pandemic in March 2020. It is a zoonotic disease that has quickly spread globally from person-to-person via respiratory droplets or through touching contaminated objects or surfa
Symptoms
It can present as an asymptomatic infection, a mild respiratory tract infection, or a severe pneumonia with respiratory failure and even death. The incubation period ranges from 2-14 days (5 days on average), and symptoms can include fever, cough, and shortness of breath.
Mechanism of Infection
Primarily transmitted between people through respiratory droplets and contact routes